Global Submission Manager (Regulatory Project Manager): (Started) Associate-(Current) Sr. Manager
Current• Lead multifaceted project plans from project initiation to close out• Develops and manages regulatory submissions and Agency interactions, from early to late phase programs in gene therapy and small molecule products, utilizing FDA, EMA, and country specific guidance• Lead complex transitional plan to transfer sponsor of an active product• Facilitates the definition of the project milestones, tasks, deliverables, key dependencies and resource requirements• Coordinates timelines, preparation, and logistics for FDA Agency Meetings• Generates and maintains status reports and other project related artifacts • Lead communication of project status, issues, schedule and accomplishments to various management and stakeholder groups, as needed• Work with Global Regulatory Program Lead to create ad-hoc requests for project related information• Regulatory timing and cross-functional coordination expertise for the following Regulatory Applications and subsequent activities, including by not limited to, initial investigational (IND/CTA) and marketing applications (MAA/BLA/NDS/NDA), response to RSIs, lifecycle management and Agency interaction prep and logistics: EMA and US Orphan Drug Designation (ODD), US Initial INDs, EMA Initial CTAs, EMA Pediatric Investigation Plans (PIP), FDA Pediatric Study Plan and PPSR, EMA Priority Medicines (PRIME), US Regenerative Medicine Advanced Therapy Designation (RMAT), US Breakthrough Designation (BTD), FDA Rare Pediatric Voucher Request, US interactions with Controlled Substance Staff (CSS), EMA/CHMP Scientific Advice Meetings, EMA Oral Explanations, FDA End of Phase Meetings, FDA Pre-IND Meeting, Pre-Marketing Application Submission Meetings, Other FDA Meetings.